BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22437768)

  • 1. [Evaluation of a strategy adopted to expand adherence to breast cancer screening in Brazilian Northeast].
    Barreto AS; Mendes MF; Thuler LC
    Rev Bras Ginecol Obstet; 2012 Feb; 34(2):86-91. PubMed ID: 22437768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Breast Biopsy With Benign Results Does Not Negatively Affect Future Screening Adherence.
    Lewin AA; Gao Y; Lin Young LL; Albert ML; Babb JS; Toth HK; Moy L; Heller SL
    J Am Coll Radiol; 2018 Apr; 15(4):622-629. PubMed ID: 29433804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers related to non-adherence in a mammography breast-screening program during the implementation period in the interior of São Paulo State, Brazil.
    Vieira RA; Lourenço TS; Mauad EC; Moreira Filho VG; Peres SV; Silva TB; Lattore Mdo R
    J Epidemiol Glob Health; 2015 Sep; 5(3):211-9. PubMed ID: 26231397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of unconventional utilization of BI-RADS category 3 assessment at opportunistic screening.
    Altas H; Tureli D; Cengic I; Kucukkaya F; Aribal E; Kaya H
    Acta Radiol; 2016 Nov; 57(11):1304-1309. PubMed ID: 26019241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance With Screening Mammography Guidelines After a False-Positive Mammogram.
    Hardesty LA; Lind KE; Gutierrez EJ
    J Am Coll Radiol; 2016 Sep; 13(9):1032-8. PubMed ID: 27233908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis for the breast cancer screening among urban populations in China, 2012-2013].
    Mi ZH; Ren JS; Zhang HZ; Li J; Wang Y; Fang Y; Shi JF; Zhang K; Zhao JB; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Oct; 50(10):887-892. PubMed ID: 27686767
    [No Abstract]   [Full Text] [Related]  

  • 8. Lesion and patient characteristics associated with malignancy after a probably benign finding on community practice mammography.
    Lehman CD; Rutter CM; Eby PR; White E; Buist DS; Taplin SH
    AJR Am J Roentgenol; 2008 Feb; 190(2):511-5. PubMed ID: 18212240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography in asymptomatic women aged 40-49 years.
    Silva FX; Katz L; Souza AS; Amorim MM
    Rev Saude Publica; 2014 Dec; 48(6):931-9. PubMed ID: 26039396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of abnormal mammography results and palpable breast abnormalities.
    Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
    Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Happens after a Diagnosis of High-Risk Breast Lesion at Stereotactic Vacuum-assisted Biopsy? An Observational Study of Postdiagnosis Management and Imaging Adherence.
    Gao Y; Albert M; Young Lin LL; Lewin AA; Babb JS; Heller SL; Moy L
    Radiology; 2018 May; 287(2):423-431. PubMed ID: 29378151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the results of mammography screening in Dubrovnik-Neretva County in the 2006-2009 period].
    Dzono-Boban A; Mratović MC; Masanović M
    Acta Med Croatica; 2010 Dec; 64(5):453-9. PubMed ID: 21692270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study.
    Cuoghi IC; da Silva Soares MF; Dos Santos GMC; Dos-Reis FJC; Poli-Neto OB; de Andrade JM; Bosquesi PL; Orlandini LF; Tiezzi DG
    J Glob Health; 2022 Oct; 12():04061. PubMed ID: 36227588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Access to early breast cancer diagnosis in the Brazilian Unified National Health System: an analysis of data from the Health Information System].
    Azevedo E Silva G; Bustamante-Teixeira MT; Aquino EM; Tomazelli JG; Dos-Santos-Silva I
    Cad Saude Publica; 2014 Jul; 30(7):1537-50. PubMed ID: 25166949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
    Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
    Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal changes in breast cancer screening coverage provided under the Brazilian National Health Service between 2008 and 2017.
    Rodrigues DCN; Freitas-Junior R; Rahal RMS; da Silveira Corrêa R; Gouveia PA; Peixoto JE; Martins E; Soares LR
    BMC Public Health; 2019 Jul; 19(1):959. PubMed ID: 31319826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The current state of the diagnostics of breast diseases in Lombardy].
    Vergnaghi D; Panizza P; Gozzi G
    Radiol Med; 2000 Nov; 100(5):314-20. PubMed ID: 11213407
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.